申込番号 |
更新日 |
ホモロジー |
E-value |
鋳型 |
リガンド |
価格 |
アノテーション |
KIN_1M17A_0001 |
2003/08/25 |
95.37% (696-1019) |
1e-117 |
1M17 |
Erlotinib |
*1 |
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); Epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) [Homo sapiens]###gi 11494380 gb AAG35789.1 AF288738_4 p170 epidermal growth factor receptor [Homo sapiens]; Length=1210 |
KIN_1M17A_0002 |
2003/08/25 |
95.37% (696-1019) |
1e-117 |
1M17 |
Erlotinib |
*1 |
GQHUE epidermal growth factor receptor precursor - human###gi 757924 emb CAA25240.1 epidermal growth factor receptor [Homo sapiens]###gi 223980 prf 1006266A epidermal growth factor receptor; Length=1210 |
KIN_1M17A_0003 |
2003/08/25 |
75.17% (1-290) |
1e-101 |
1M17 |
Erlotinib |
*1 |
protooncogene protein [Homo sapiens]; Length=295 |
KIN_1M17A_0004 |
2003/08/25 |
75.54% (704-1026) |
1e-117 |
1M17 |
Erlotinib |
*1 |
gi 86984 pir A24571 protein-tyrosine kinase (EC 2.7.1.112) erbB2 precursor - human###gi 31198 emb CAA27060.1 c-erb-B-2 precursor [Homo sapiens]###gi 224874 prf 1202345A gene c-erbB2; Length=1255 |
KIN_1M17A_0005 |
2003/08/25 |
75.54% (704-1026) |
1e-117 |
1M17 |
Erlotinib |
*1 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) [Homo sapiens]###gi 306840 gb AAA75493.1 HER2 receptor; Length=1255 |
KIN_1M17A_0006 |
2003/08/25 |
75.00% (702-1025) |
1e-122 |
1M17 |
Erlotinib |
*1 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4; avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4; v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4 [Homo sapiens]###gi 422854 pir A47253 epidermal growth factor receptor, HER4 - human###gi 337360 gb AAB59446.1 receptor tyrosine kinase; Length=1308 |
KIN_1M17A_0007 |
2003/08/25 |
31.94% (713-1041) |
1e-112 |
1M17 |
Erlotinib |
*1 |
ret proto-oncogene isoform a; RET transforming sequence; hydroxyaryl-protein kinase; cadherin family member 12; oncogene RET [Homo sapiens]###gi 10862705 ref NP_000314.1 ret proto-oncogene isoform a; RET transforming sequence; hydroxyaryl-protein kinase; cadherin family member 12; oncogene RET [Homo sapiens]###gi 88522 pir S05582 protein-tyrosine kinase (EC 2.7.1.112) ret precursor - human; Length=1114 |
KIN_1M17A_0008 |
2003/08/25 |
31.94% (459-787) |
1e-112 |
1M17 |
Erlotinib |
*1 |
ret tyrosine kinase (AA 1 - 860) [Homo sapiens]; Length=860 |
KIN_1M17A_0009 |
2003/08/25 |
31.94% (713-1041) |
1e-112 |
1M17 |
Erlotinib |
*1 |
ret proto-oncogene isoform c; RET transforming sequence; hydroxyaryl-protein kinase; cadherin family member 12; oncogene RET [Homo sapiens]; Length=1072 |
KIN_1M17A_0010 |
2003/08/25 |
31.94% (713-1041) |
1e-112 |
1M17 |
Erlotinib |
*1 |
ret proto-oncogene isoform b; RET transforming sequence; hydroxyaryl-protein kinase; cadherin family member 12; oncogene RET [Homo sapiens]; Length=1106 |
KIN_1M17A_0011 |
2003/08/25 |
33.01% (432-737) |
1e-111 |
1M17 |
Erlotinib |
*1 |
PTK2 protein tyrosine kinase 2 isoform b; focal adhesion kinase 1 [Homo sapiens]; Length=1074 |
KIN_1M17A_0012 |
2003/08/25 |
33.01% (410-715) |
1e-111 |
1M17 |
Erlotinib |
*1 |
PTK2 protein tyrosine kinase 2 isoform a; focal adhesion kinase 1 [Homo sapiens]###gi 2135124 pir I53012 focal adhesion kinase - human###gi 439875 gb AAA58469.1 focal adhesion kinase; Length=1052 |
KIN_1M17A_0013 |
2003/08/25 |
33.01% (410-715) |
1e-111 |
1M17 |
Erlotinib |
*1 |
Similar to PTK2 protein tyrosine kinase 2 [Homo sapiens]; Length=1006 |
KIN_1M17A_0014 |
2003/08/25 |
31.02% (824-1121) |
3e-98 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase with immunoglobulin and epidermal growth factor homology domains; Tyrosine kinase with immunoglobulin and epidermal growth factor [Homo sapiens]###gi 396815 emb CAA43290.1 receptor tyrosine kinase [Homo sapiens]###gi 23398605 gb AAH38239.1 tyrosine kinase with immunoglobulin and epidermal growth factor homology domains [Homo sapiens]; Length=1138 |
KIN_1M17A_0015 |
2003/08/25 |
33.12% (78-383) |
1e-110 |
1M17 |
Erlotinib |
*1 |
unnamed protein product [Homo sapiens]; Length=720 |
KIN_1M17A_0016 |
2003/08/25 |
33.98% (145-452) |
1e-103 |
1M17 |
Erlotinib |
*1 |
Similar to TYRO3 protein tyrosine kinase [Homo sapiens]; Length=522 |
KIN_1M17A_0017 |
2003/08/25 |
37.00% (1-272) |
5e-99 |
1M17 |
Erlotinib |
*1 |
TYRO3 [Homo sapiens]; Length=272 |
KIN_1M17A_0018 |
2003/08/25 |
31.85% (689-1018) |
1e-110 |
1M17 |
Erlotinib |
*1 |
RET tyrosine kinase receptor [Homo sapiens]; Length=1091 |
KIN_1M17A_0019 |
2003/08/25 |
31.70% (809-1109) |
3e-99 |
1M17 |
Erlotinib |
*1 |
TEK tyrosine kinase, endothelial [Homo sapiens]###gi 2136092 pir I58388 protein-tyrosine kinase (EC 2.7.1.112), receptor type tek precursor - human###gi 292824 gb AAA61139.1 receptor protein-tyrosine kinase; Length=1124 |
KIN_1M17A_0020 |
2003/08/25 |
31.37% (786-1086) |
3e-98 |
1M17 |
Erlotinib |
*1 |
TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) [Homo sapiens]; Length=1101 |
KIN_1M17A_0021 |
2003/08/25 |
30.18% (229-563) |
1e-106 |
1M17 |
Erlotinib |
*1 |
PC1225 protein-tyrosine kinase (EC 2.7.1.112) FAK - human (fragment)###gi 182395 gb AAA35819.1 focal adhesion kinase [Homo sapiens]; Length=879 |
KIN_1M17A_0022 |
2003/08/25 |
31.94% (498-826) |
1e-111 |
1M17 |
Erlotinib |
*1 |
I38153 gene retII protein - human###gi 36009 emb CAA33787.1 retII [Homo sapiens]; Length=899 |
KIN_1M17A_0023 |
2003/08/25 |
33.98% (513-820) |
1e-104 |
1M17 |
Erlotinib |
*1 |
TYRO3 protein tyrosine kinase; Brt; Dtk; Sky; Tif; Tyro3 protein tyrosine kinase (sea-related receptor tyrosine kinase); tyrosine-protein kinase receptor TYRO3 precursor [Homo sapiens]###gi 627596 pir A53743 protein-tyrosine kinase (EC 2.7.1.112) tyro3 precursor - human###gi 463470 gb AAA19236.1 Rse###gi 624881 dbj BAA04467.1 Sky [Homo sapiens]; Length=890 |
KIN_1M17A_0024 |
2003/08/25 |
34.30% (507-814) |
1e-104 |
1M17 |
Erlotinib |
*1 |
protein-tyrosine kinase [Homo sapiens]; Length=884 |
KIN_1M17A_0025 |
2003/08/25 |
27.91% (460-760) |
1e-101 |
1M17 |
Erlotinib |
*1 |
receptor tyrosine kinase-like orphan receptor 1; neurotrophic tyrosine kinase receptor-related 1 [Homo sapiens]###gi 346351 pir A45082 neurotrophic receptor ror1 precursor - human###gi 337465 gb AAA60275.1 transmembrane receptor; Length=937 |
KIN_1M17A_0026 |
2003/08/25 |
35.18% (625-930) |
1e-111 |
1M17 |
Erlotinib |
*1 |
EphA1; eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1); eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence); ephrin receptor EphA1 [Homo sapiens]###gi 339717 gb AAA36747.1 tyrosine kinase receptor precursor (put.); putative; Length=984 |
KIN_1M17A_0027 |
2003/08/25 |
31.13% (109-405) |
2e-97 |
1M17 |
Erlotinib |
*1 |
AF217976_1 unknown [Homo sapiens]; Length=421 |
KIN_1M17A_0028 |
2003/08/25 |
28.43% (1013-1325) |
1e-122 |
1M17 |
Erlotinib |
*1 |
insulin receptor [Homo sapiens]###gi 307070 gb AAA59174.1 insulin receptor precursor; Length=1382 |
KIN_1M17A_0029 |
2003/08/25 |
31.32% (217-489) |
1e-118 |
1M17 |
Erlotinib |
*1 |
AF228313_1 tyrosine kinase LCK [Homo sapiens]; Length=496 |
KIN_1M17A_0030 |
2003/08/25 |
30.12% (429-750) |
1e-123 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 3 [Homo sapiens]; Length=771 |
KIN_1M17A_0031 |
2003/08/25 |
30.12% (427-748) |
1e-124 |
1M17 |
Erlotinib |
*1 |
AF487554_1 fibroblast growth factor receptor 3 [Homo sapiens]; Length=769 |
KIN_1M17A_0032 |
2003/08/25 |
34.20% (513-818) |
1e-103 |
1M17 |
Erlotinib |
*1 |
similar to TYRO3 protein tyrosine kinase [Homo sapiens]; Length=890 |
KIN_1M17A_0033 |
2003/08/25 |
31.39% (550-817) |
1e-104 |
1M17 |
Erlotinib |
*1 |
V-FES feline sarcoma viral/V-FPS fujinami avian sarcoma viral oncogene homolog; Oncogene FES, feline sarcoma virus; feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog [Homo sapiens]###gi 66834 pir TVHUFF protein-tyrosine kinase (EC 2.7.1.112) fes/fps - human###gi 31349 emb CAA29619.1 NCP92 [Homo sapiens]###gi 23271525 gb AAH35357.1 feline sarcoma oncogene [Homo sapiens]; Length=822 |
KIN_1M17A_0034 |
2003/08/25 |
31.40% (212-503) |
1e-106 |
1M17 |
Erlotinib |
*1 |
55 kd protein [Homo sapiens]; Length=503 |
KIN_1M17A_0035 |
2003/08/25 |
31.65% (471-763) |
1e-120 |
1M17 |
Erlotinib |
*1 |
K-sam-IIO3 [Homo sapiens]; Length=768 |
KIN_1M17A_0036 |
2003/08/25 |
31.08% (477-772) |
1e-120 |
1M17 |
Erlotinib |
*1 |
K-sam-IIH3 [Homo sapiens]; Length=830 |
KIN_1M17A_0037 |
2003/08/25 |
31.65% (471-763) |
1e-120 |
1M17 |
Erlotinib |
*1 |
K-sam-IIO1 [Homo sapiens]; Length=771 |
KIN_1M17A_0038 |
2003/08/25 |
31.99% (615-935) |
1e-130 |
1M17 |
Erlotinib |
*1 |
gi 542989 pir S37627 protein-tyrosine kinase (EC 2.7.1.112), receptor-type - human###gi 406868 emb CAA53021.1 protein tyrosine kinase-receptor [Homo sapiens]; Length=998 |
KIN_1M17A_0039 |
2003/08/25 |
31.99% (615-935) |
1e-130 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphB3 precursor; EPH-like tyrosine kinase-2; Hek2; Tyro6; human embryo kinase 2; ephrin receptor EphB3 [Homo sapiens]; Length=998 |
KIN_1M17A_0040 |
2003/08/25 |
30.39% (135-439) |
1e-107 |
1M17 |
Erlotinib |
*1 |
trk-2h polypeptide [Homo sapiens]; Length=439 |
KIN_1M17A_0041 |
2003/08/25 |
31.99% (258-550) |
1e-121 |
1M17 |
Erlotinib |
*1 |
fibroblast growth receptor 2 IgIIIb isoform [Homo sapiens]; Length=555 |
KIN_1M17A_0042 |
2003/08/25 |
31.99% (471-763) |
1e-121 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 7 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 87415 pir S16236 fibroblast growth factor receptor precursor - human###gi 29432 emb CAA39654.1 fibroblast growth factor (FGR) receptor [Homo sapiens]; Length=769 |
KIN_1M17A_0043 |
2003/08/25 |
31.99% (470-762) |
1e-121 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 6 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=768 |
KIN_1M17A_0044 |
2003/08/25 |
34.89% (601-920) |
1e-136 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphB1 precursor; eph tyrosine kinase 2; ephrin receptor EphB1 [Homo sapiens]###gi 1100112 gb AAB08520.1 protein tyrosine kinase [Homo sapiens]; Length=984 |
KIN_1M17A_0045 |
2003/08/25 |
34.58% (169-488) |
1e-132 |
1M17 |
Erlotinib |
*1 |
dJ74M1.1.2 (tyrosine kinase isosform 2) [Homo sapiens]; Length=621 |
KIN_1M17A_0046 |
2003/08/25 |
34.58% (603-922) |
1e-133 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphB2 isoform 1 precursor; developmentally-regulated eph-related tyrosine kinase; elk-related tyrosine kinase; eph tyrosine kinase 3 [Homo sapiens]###gi 2739056 gb AAB94602.1 protein-tyrosine kinase EPHB2v [Homo sapiens]; Length=1055 |
KIN_1M17A_0047 |
2003/08/25 |
34.58% (169-488) |
1e-132 |
1M17 |
Erlotinib |
*1 |
dJ74M1.1.1 (tyrosine kinase isoform 1) [Homo sapiens]; Length=552 |
KIN_1M17A_0048 |
2003/08/25 |
30.03% (467-795) |
1e-127 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 1 isoform 1 precursor; fms-related tyrosine kinase-2; heparin-binding growth factor receptor; FMS-like tyrosine kinase 2; basic fibroblast growth factor receptor 1; N-sam tyrosine kinase; FLG protein; protein-tyrosine kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 476559 pir TVHUFG fibroblast growth factor receptor 1 precursor - human###gi 31378 emb CAA37015.1 fibroblast growth factor receptor-FLG precursor [Homo sapiens]###gi 31393 emb CAA40403.1 Fibroblast Growth Factor Receptor, 3-Ig Domain+2 AA insert [Homo sapiens]###gi 35110 emb CAA47375.1 fibroblast growth factor receptor [Homo sapiens]; Length=822 |
KIN_1M17A_0049 |
2003/08/25 |
30.03% (467-795) |
1e-127 |
1M17 |
Erlotinib |
*1 |
precursor polypeptide (AA -21 to 801) [Homo sapiens]; Length=822 |
KIN_1M17A_0050 |
2003/08/25 |
30.03% (465-793) |
1e-127 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 1 isoform 2 precursor; fms-related tyrosine kinase-2; heparin-binding growth factor receptor; FMS-like tyrosine kinase 2; basic fibroblast growth factor receptor 1; N-sam tyrosine kinase; FLG protein; protein-tyrosine kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 31391 emb CAA40402.1 Fibroblast Growth Factor Receptor, 3 Ig-Domain Form [Homo sapiens]###gi 182561 gb AAA35840.1 fibroblast growth factor receptor; Length=820 |
KIN_1M17A_0051 |
2003/08/25 |
30.03% (465-793) |
1e-127 |
1M17 |
Erlotinib |
*1 |
similar to fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) [Homo sapiens]; Length=820 |
KIN_1M17A_0052 |
2003/08/25 |
30.03% (465-793) |
1e-127 |
1M17 |
Erlotinib |
*1 |
FGF receptor-1 precursor [Homo sapiens]; Length=820 |
KIN_1M17A_0053 |
2003/08/25 |
30.03% (376-704) |
1e-126 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 1 isoform 4 precursor; fms-related tyrosine kinase-2; heparin-binding growth factor receptor; FMS-like tyrosine kinase 2; basic fibroblast growth factor receptor 1; N-sam tyrosine kinase; FLG protein; protein-tyrosine kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 31387 emb CAA40404.1 Fibroblast Growth Factor Receptor, 2 Ig-Domain Form [Homo sapiens]; Length=731 |
KIN_1M17A_0054 |
2003/08/25 |
30.03% (267-595) |
1e-126 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase [Homo sapiens]; Length=622 |
KIN_1M17A_0055 |
2003/08/25 |
30.85% (69-342) |
1e-118 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase [Homo sapiens]; Length=348 |
KIN_1M17A_0056 |
2003/08/25 |
30.85% (226-499) |
1e-118 |
1M17 |
Erlotinib |
*1 |
unnamed protein product [Homo sapiens]; Length=505 |
KIN_1M17A_0057 |
2003/08/25 |
30.85% (226-499) |
1e-118 |
1M17 |
Erlotinib |
*1 |
TVHUHC protein-tyrosine kinase (EC 2.7.1.112) hck - human###gi 306833 gb AAA52644.1 protein-tyrosine kinase###gi 15680177 gb AAH14435.1 AAH14435 Unknown (protein for MGC:22922) [Homo sapiens]; Length=505 |
KIN_1M17A_0058 |
2003/08/25 |
30.39% (287-591) |
1e-107 |
1M17 |
Erlotinib |
*1 |
p68 TRK-T3 oncoprotein [Homo sapiens]; Length=591 |
KIN_1M17A_0059 |
2003/08/25 |
31.91% (211-484) |
1e-115 |
1M17 |
Erlotinib |
*1 |
Lyn B protein [Homo sapiens]###gi 741028 prf 2006286C protein Tyr kinase LYN; Length=491 |
KIN_1M17A_0060 |
2003/08/25 |
34.89% (601-920) |
1e-134 |
1M17 |
Erlotinib |
*1 |
Eph-like receptor tyrosine kinase hEphB1 [Homo sapiens]; Length=984 |
KIN_1M17A_0061 |
2003/08/25 |
30.85% (226-499) |
1e-118 |
1M17 |
Erlotinib |
*1 |
hemopoietic cell kinase [Homo sapiens]###gi 306832 gb AAA52643.1 protein-tyrosine kinase; Length=505 |
KIN_1M17A_0062 |
2003/08/25 |
30.85% (104-377) |
1e-118 |
1M17 |
Erlotinib |
*1 |
dJ836N17.1 (hemopoietic cell kinase) [Homo sapiens]; Length=383 |
KIN_1M17A_0063 |
2003/08/25 |
35.53% (321-637) |
1e-114 |
1M17 |
Erlotinib |
*1 |
receptor tyrosine kinase eph [Homo sapiens]; Length=691 |
KIN_1M17A_0064 |
2003/08/25 |
32.01% (72-341) |
1e-121 |
1M17 |
Erlotinib |
*1 |
c-src [Homo sapiens]; Length=351 |
KIN_1M17A_0065 |
2003/08/25 |
31.43% (248-519) |
1e-115 |
1M17 |
Erlotinib |
*1 |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene; Oncogene FGR [Homo sapiens]###gi 66801 pir TVHUFR protein-tyrosine kinase (EC 2.7.1.112) fgr - human###gi 182574 gb AAA52451.1 p55-c-fgr protein###gi 12803975 gb AAH02836.1 AAH02836 Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog [Homo sapiens]; Length=529 |
KIN_1M17A_0066 |
2003/08/25 |
34.58% (615-934) |
1e-134 |
1M17 |
Erlotinib |
*1 |
similar to dJ74M1.1.2 (tyrosine kinase isosform 2) [Homo sapiens] [Rattus norvegicus]; Length=1075 |
KIN_1M17A_0067 |
2003/08/25 |
33.01% (38-343) |
1e-110 |
1M17 |
Erlotinib |
*1 |
Similar to PTK2 protein tyrosine kinase 2 [Homo sapiens]; Length=680 |
KIN_1M17A_0068 |
2003/08/25 |
31.32% (230-502) |
1e-118 |
1M17 |
Erlotinib |
*1 |
gi 66786 pir OKHULK protein-tyrosine kinase (EC 2.7.1.112) lck - human###gi 825687 emb CAA32211.1 tyrosine kinase [Homo sapiens]###gi 28317393 tpe CAD55807.1 TPA: protein tyrosine kinase [Homo sapiens]; Length=509 |
KIN_1M17A_0069 |
2003/08/25 |
32.19% (851-1141) |
3e-76 |
1M17 |
Erlotinib |
*1 |
janus kinase 1 [Homo sapiens]###gi 190735 gb AAA36527.1 protein-tyrosine kinase; Length=1142 |
KIN_1M17A_0070 |
2003/08/25 |
31.94% (713-1041) |
1e-112 |
1M17 |
Erlotinib |
*1 |
AAH04257 ret proto-oncogene (multiple endocrine neoplasia MEN2A, MEN2B and medullary thyroid carcinoma 1, Hirschsprung disease) [Homo sapiens]; Length=1072 |
KIN_1M17A_0071 |
2003/08/25 |
34.47% (598-918) |
1e-133 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase precursor [Homo sapiens]; Length=981 |
KIN_1M17A_0072 |
2003/08/25 |
30.12% (471-788) |
1e-122 |
1M17 |
Erlotinib |
*1 |
K-sam-IIH1 [Homo sapiens]; Length=819 |
KIN_1M17A_0073 |
2003/08/25 |
30.77% (550-817) |
1e-104 |
1M17 |
Erlotinib |
*1 |
gi 29891 emb CAA36438.1 c-fes [Homo sapiens]; Length=822 |
KIN_1M17A_0074 |
2003/08/25 |
29.39% (556-867) |
1e-106 |
1M17 |
Erlotinib |
*1 |
muscle, skeletal, receptor tyrosine kinase; Receptor tyrosine kinase MuSK [Homo sapiens]###gi 2253312 gb AAB63044.1 muscle specific tyrosine kinase receptor [Homo sapiens]; Length=869 |
KIN_1M17A_0075 |
2003/08/25 |
34.89% (590-909) |
1e-135 |
1M17 |
Erlotinib |
*1 |
Eph-like receptor tyrosine kinase hEphB1b [Homo sapiens]; Length=973 |
KIN_1M17A_0076 |
2003/08/25 |
32.97% (257-526) |
1e-122 |
1M17 |
Erlotinib |
*1 |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog; Protooncogene SRC, Rous sarcoma; v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog [Homo sapiens]###gi 338460 gb AAA60584.1 pp60 c-src-1 protein###gi 13374724 emb CAC34523.1 dJ823N20.1.2 (v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog, isoform 2) [Homo sapiens]###gi 15079460 gb AAH11566.1 AAH11566 Similar to v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog [Homo sapiens]; Length=536 |
KIN_1M17A_0077 |
2003/08/25 |
32.74% (261-532) |
1e-122 |
1M17 |
Erlotinib |
*1 |
TVHUSC protein-tyrosine kinase (EC 2.7.1.112) src, neuronal - human###gi 10635153 emb CAC10573.1 dJ823N20.1.1 (v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (a tyrosine-protein kinase (EC 2.7.1.112)) isoform 1) [Homo sapiens]; Length=542 |
KIN_1M17A_0078 |
2003/08/25 |
32.47% (434-696) |
1e-102 |
1M17 |
Erlotinib |
*1 |
Etk/Bmx cytosolic tyrosine kinase [Homo sapiens]; Length=697 |
KIN_1M17A_0079 |
2003/08/25 |
31.77% (260-528) |
1e-120 |
1M17 |
Erlotinib |
*1 |
protein-tyrosine kinase fyn isoform a; proto-oncogene tyrosine-protein kinase fyn; src/yes-related novel gene; src-like kinase; c-syn protooncogene; tyrosine kinase p59fyn(T); OKT3-induced calcium influx regulator [Homo sapiens]###gi 66783 pir TVHUSY protein-tyrosine kinase (EC 2.7.1.112) fyn, splice form B [validated] - human###gi 181172 gb AAC08285.1 c-syn protooncogene [Homo sapiens]; Length=537 |
KIN_1M17A_0080 |
2003/08/25 |
29.23% (471-790) |
1e-120 |
1M17 |
Erlotinib |
*1 |
K-sam-IIH2 [Homo sapiens]; Length=819 |
KIN_1M17A_0081 |
2003/08/25 |
27.07% (429-742) |
1e-95 |
1M17 |
Erlotinib |
*1 |
ROR2 protein [Homo sapiens]; Length=910 |
KIN_1M17A_0082 |
2003/08/25 |
34.17% (603-920) |
1e-128 |
1M17 |
Erlotinib |
*1 |
EphA3; Ephrin receptor EphA3 (human embryo kinase 1); eph-like tyrosine kinase 1 (human embryo kinase 1); ephrin receptor EphA3 [Homo sapiens]###gi 12003435 gb AAG43576.1 AF213459_1 ephrin receptor EPHA3 complete form [Homo sapiens]; Length=983 |
KIN_1M17A_0083 |
2003/08/25 |
33.75% (603-921) |
1e-132 |
1M17 |
Erlotinib |
*1 |
EphA4; Hek8; TYRO1 protein tyrosine kinase; ephrin receptor EphA4 [Homo sapiens]###gi 7434434 pir I78844 receptor protein-tyrosine kinase - human###gi 551614 gb AAA74246.1 receptor protein-tyrosine kinase; Length=986 |
KIN_1M17A_0084 |
2003/08/25 |
33.86% (595-913) |
1e-124 |
1M17 |
Erlotinib |
*1 |
EphA2 [Homo sapiens]; Length=976 |
KIN_1M17A_0085 |
2003/08/25 |
29.28% (936-1256) |
1e-120 |
1M17 |
Erlotinib |
*1 |
insulin receptor-related receptor [Homo sapiens]; Length=1268 |
KIN_1M17A_0086 |
2003/08/25 |
33.86% (595-913) |
1e-124 |
1M17 |
Erlotinib |
*1 |
EphA2; ephrin receptor EphA2; epithelial cell receptor protein tyrosine kinase [Homo sapiens]###gi 107496 pir A36355 protein-tyrosine kinase (EC 2.7.1.112) eck precursor - human###gi 181944 gb AAA53375.1 protein-tyrosine kinase; Length=976 |
KIN_1M17A_0087 |
2003/08/25 |
35.71% (657-949) |
1e-127 |
1M17 |
Erlotinib |
*1 |
EphA5; Hek7; ephrin receptor EphA5; TYRO4 protein tyrosine kinase [Homo sapiens]###gi 1177466 emb CAA64700.1 EHK-1 receptor tyrosine kinase [Homo sapiens]; Length=1037 |
KIN_1M17A_0088 |
2003/08/25 |
31.77% (266-534) |
1e-121 |
1M17 |
Erlotinib |
*1 |
viral oncogene yes-1 homolog 1; proto-oncogene tyrosine-protein kinase YES; Yamaguchi sarcoma oncogene; cellular yes-1 protein [Homo sapiens]###gi 66799 pir TVHUYS protein-tyrosine kinase (EC 2.7.1.112) yes-1 - human###gi 181268 gb AAA35735.1 cellular yes-1 protein###gi 29124496 gb AAH48960.1 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 [Homo sapiens]; Length=543 |
KIN_1M17A_0089 |
2003/08/25 |
31.32% (230-502) |
1e-118 |
1M17 |
Erlotinib |
*1 |
lymphocyte-specific protein tyrosine kinase; oncogene LCK; membrane associated protein tyrosine kinase [Homo sapiens]###gi 34295 emb CAA31884.1 lck protein (AA 1-509) [Homo sapiens]; Length=509 |
KIN_1M17A_0090 |
2003/08/25 |
30.65% (459-781) |
1e-117 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 4 isoform 1 precursor; tyrosine kinase related to fibroblast growth factor receptor; tyrosylprotein kinase; protein-tyrosine kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 20153207 gb AAM13666.1 AF487555_1 fibroblast growth factor receptor 4 [Homo sapiens]; Length=802 |
KIN_1M17A_0091 |
2003/08/25 |
29.82% (471-798) |
1e-128 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 5 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 339711 gb AAA61188.1 TK14 protein; Length=822 |
KIN_1M17A_0092 |
2003/08/25 |
29.35% (533-839) |
1e-105 |
1M17 |
Erlotinib |
*1 |
TRKC [Homo sapiens]; Length=839 |
KIN_1M17A_0093 |
2003/08/25 |
32.36% (582-889) |
1e-106 |
1M17 |
Erlotinib |
*1 |
c-mer proto-oncogene tyrosine kinase [Homo sapiens]###gi 7434404 pir I38547 novel cellular proto-oncogene - human###gi 505665 gb AAB60430.1 novel cellular proto-oncogene; Length=999 |
KIN_1M17A_0094 |
2003/08/25 |
32.57% (561-866) |
1e-106 |
1M17 |
Erlotinib |
*1 |
MER receptor tyrosine kinase [Homo sapiens]; Length=978 |
KIN_1M17A_0095 |
2003/08/25 |
29.35% (285-577) |
3e-76 |
1M17 |
Erlotinib |
*1 |
receptor tyrosine kinase [Homo sapiens]; Length=577 |
KIN_1M17A_0096 |
2003/08/25 |
29.33% (123-405) |
2e-76 |
1M17 |
Erlotinib |
*1 |
AAH21700 Unknown (protein for IMAGE:4052080) [Homo sapiens]; Length=405 |
KIN_1M17A_0097 |
2003/08/25 |
29.01% (312-604) |
4e-76 |
1M17 |
Erlotinib |
*1 |
RYK receptor-like tyrosine kinase precursor; hydroxyaryl-protein kinase [Homo sapiens] |
KIN_1M17A_0098 |
2003/08/25 |
28.98% (325-607) |
9e-75 |
1M17 |
Erlotinib |
*1 |
I37560 protein-tyrosine kinase (EC 2.7.1.112) ryk - human###gi 32462 emb CAA49591.1 h-ryk [Homo sapiens]; Length=607 |
KIN_1M17A_0099 |
2003/08/25 |
31.94% (226-504) |
1e-113 |
1M17 |
Erlotinib |
*1 |
protein tyrosine kinase [Homo sapiens]; Length=505 |
KIN_1M17A_0100 |
2003/08/25 |
32.29% (226-504) |
1e-114 |
1M17 |
Erlotinib |
*1 |
AAH07371 Unknown (protein for MGC:16168) [Homo sapiens]###gi 21595367 gb AAH32413.1 B lymphoid tyrosine kinase [Homo sapiens]; Length=505 |
KIN_1M17A_0101 |
2003/08/25 |
29.28% (98-417) |
1e-103 |
1M17 |
Erlotinib |
*1 |
A43625 protein-tyrosine kinase (EC 2.7.1.112) ltk (version 2) - human###gi 34422 emb CAA36460.1 ltk [Homo sapiens]; Length=464 |
KIN_1M17A_0102 |
2003/08/25 |
33.99% (597-898) |
1e-125 |
1M17 |
Erlotinib |
*1 |
receptor protein tyrosine kinase variant EphB4v1 [Homo sapiens]; Length=935 |
KIN_1M17A_0103 |
2003/08/25 |
32.81% (615-933) |
1e-130 |
1M17 |
Erlotinib |
*1 |
EphA7; Hek11; ephrin receptor EphA7 [Homo sapiens]###gi 2136091 pir I58351 receptor protein-tyrosine kinase - human###gi 551608 gb AAA74243.1 receptor protein-tyrosine kinase; Length=998 |
KIN_1M17A_0104 |
2003/08/25 |
31.94% (226-504) |
1e-114 |
1M17 |
Erlotinib |
*1 |
B lymphoid tyrosine kinase; BLK nonreceptor tyrosine kinase [Homo sapiens]###gi 2117797 pir I37206 protein-tyrosine kinase (EC 2.7.1.112) blk - human###gi 601952 emb CAA83965.1 Protein-Tyrosine Kinase [Homo sapiens]; Length=505 |
KIN_1M17A_0105 |
2003/08/25 |
35.53% (606-922) |
1e-113 |
1M17 |
Erlotinib |
*1 |
gi 5453122 gb AAD43440.1 receptor tyrosine kinase [Homo sapiens]; Length=976 |
KIN_1M17A_0106 |
2003/08/25 |
30.03% (465-793) |
1e-127 |
1M17 |
Erlotinib |
*1 |
similar to fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) [Homo sapiens]; Length=820 |
KIN_1M17A_0107 |
2003/08/25 |
30.65% (459-781) |
1e-117 |
1M17 |
Erlotinib |
*1 |
TVHUF4 fibroblast growth factor receptor 4 precursor - human###gi 31372 emb CAA40490.1 fibroblast growth factor receptor [Homo sapiens]; Length=802 |
KIN_1M17A_0108 |
2003/08/25 |
30.65% (459-781) |
1e-117 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor 4 [Homo sapiens]; Length=802 |
KIN_1M17A_0109 |
2003/08/25 |
30.63% (471-786) |
1e-124 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 10 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=788 |
KIN_1M17A_0110 |
2003/08/25 |
34.47% (95-415) |
1e-132 |
1M17 |
Erlotinib |
*1 |
A57174 protein-tyrosine kinase (EC 2.7.1.112) erk - human (fragment)###gi 1060895 dbj BAA07073.1 large erk/cek5 tyrosine kinase [Homo sapiens]###gi 1095645 prf 2109312A receptor Tyr kinase; Length=478 |
KIN_1M17A_0111 |
2003/08/25 |
33.11% (1075-1378) |
1e-101 |
1M17 |
Erlotinib |
*1 |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) [Homo sapiens]###gi 2136057 pir I38185 protein-tyrosine kinase (EC 2.7.1.112), receptor type ron - human###gi 36110 emb CAA49634.1 tyrosine kinase [Homo sapiens]; Length=1400 |
KIN_1M17A_0112 |
2003/08/25 |
29.03% (533-839) |
1e-105 |
1M17 |
Erlotinib |
*1 |
gi 2117846 pir I73632 neurotrophin-3 receptor precursor - human###gi 913722 gb AAB33111.1 trkC [Homo sapiens]###gi 1093346 prf 2103287B trkC gene; Length=839 |
KIN_1M17A_0113 |
2003/08/25 |
32.61% (455-775) |
1e-129 |
1M17 |
Erlotinib |
*1 |
AAH04264 Similar to EphB4 [Homo sapiens]; Length=845 |
KIN_1M17A_0114 |
2003/08/25 |
32.61% (597-917) |
1e-128 |
1M17 |
Erlotinib |
*1 |
gi 627587 pir A54092 protein-tyrosine kinase (EC 2.7.1.112) htk precursor - human###gi 13383505 gb AAK21010.1 ephrin type-B receptor 4 precursor [Homo sapiens]###gi 16209618 gb AAL14194.1 receptor protein tyrosine kinase EphB4 [Homo sapiens]; Length=987 |
KIN_1M17A_0115 |
2003/08/25 |
32.61% (597-917) |
1e-128 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphB4 precursor; Ephrin receptor EphB4 (hepatoma transmembrane kinase); Tyro11; ephrin receptor EphB4; hepatoma transmembrane kinase [Homo sapiens]; Length=987 |
KIN_1M17A_0116 |
2003/08/25 |
30.10% (21-318) |
1e-105 |
1M17 |
Erlotinib |
*1 |
AF125808_1 ETS related protein-neurotrophic receptor tyrosine kinase fusion protein [Homo sapiens]; Length=318 |
KIN_1M17A_0117 |
2003/08/25 |
32.54% (892-1184) |
5e-71 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase 2 [Homo sapiens]###gi 1360649 pir TVHUY2 protein-tyrosine kinase (EC 2.7.1.112) tyk2 - human###gi 37504 emb CAA38449.1 protein tyrosine kinase [Homo sapiens]; Length=1187 |
KIN_1M17A_0118 |
2003/08/25 |
28.43% (1001-1313) |
1e-122 |
1M17 |
Erlotinib |
*1 |
insulin receptor precursor [Homo sapiens]; Length=1370 |
KIN_1M17A_0119 |
2003/08/25 |
30.46% (617-940) |
1e-120 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphA8 precursor; ephrin type-A receptor 8 precursor; eph- and elk-related tyrosine kinase; tyrosylprotein kinase; tyrosine-protein kinase receptor eek; protein-tyrosine kinase; hydroxyaryl-protein kinase [Homo sapiens] |
KIN_1M17A_0120 |
2003/08/25 |
30.46% (465-788) |
1e-120 |
1M17 |
Erlotinib |
*1 |
KIAA1459 protein [Homo sapiens]; Length=853 |
KIN_1M17A_0121 |
2003/08/25 |
29.82% (470-797) |
1e-128 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 1 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 2144424 pir TVHUF2 fibroblast growth factor receptor 2 precursor - human###gi 31374 emb CAA37014.1 fibroblast growth factor receptor-BEK precursor [Homo sapiens]###gi 186780 gb AAA59470.1 fibroblast growth factor receptor###gi 1296625 emb CAA96492.1 FGFR2 [Homo sapiens]; Length=821 |
KIN_1M17A_0122 |
2003/08/25 |
29.82% (469-796) |
1e-128 |
1M17 |
Erlotinib |
*1 |
keratinocyte growth factor receptor 2 isoform KGFR [Homo sapiens]; Length=820 |
KIN_1M17A_0123 |
2003/08/25 |
29.82% (380-707) |
1e-127 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 8 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=731 |
KIN_1M17A_0124 |
2003/08/25 |
29.52% (354-681) |
1e-126 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 13 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=705 |
KIN_1M17A_0125 |
2003/08/25 |
30.72% (533-822) |
1e-111 |
1M17 |
Erlotinib |
*1 |
gi 1082638 pir A56853 brain-derived neurotrophic factor receptor precursor - human###gi 530791 gb AAC51371.1 tyrosine kinase receptor p145TRK-B###gi 913718 gb AAB33109.1 trkB [Homo sapiens]###gi 15217077 gb AAK92490.1 AF400441_1 neurotrophic tyrosine kinase receptor type 2 [Homo sapiens]###gi 1093345 prf 2103287A trkB gene; Length=822 |
KIN_1M17A_0126 |
2003/08/25 |
33.79% (9-298) |
1e-93 |
1M17 |
Erlotinib |
*1 |
truncated ZAP kinase [Homo sapiens]; Length=312 |
KIN_1M17A_0127 |
2003/08/25 |
30.94% (531-848) |
1e-105 |
1M17 |
Erlotinib |
*1 |
Unknown (protein for MGC:34202) [Homo sapiens]; Length=894 |
KIN_1M17A_0128 |
2003/08/25 |
30.94% (522-839) |
1e-105 |
1M17 |
Erlotinib |
*1 |
AXL receptor tyrosine kinase isoform 2; AXL transforming sequence/gene; oncogene AXL [Homo sapiens]; Length=885 |
KIN_1M17A_0129 |
2003/08/25 |
28.42% (322-606) |
3e-72 |
1M17 |
Erlotinib |
*1 |
related to receptor tyrosine kinase [Homo sapiens]; Length=606 |
KIN_1M17A_0130 |
2003/08/25 |
32.59% (412-673) |
1e-102 |
1M17 |
Erlotinib |
*1 |
BMX non-receptor tyrosine kinase [Homo sapiens]###gi 2117819 pir S60612 protein-tyrosine kinase (EC 2.7.1.112) Bmx - human###gi 951235 emb CAA58169.1 bmx [Homo sapiens]###gi 16741712 gb AAH16652.1 AAH16652 BMX non-receptor tyrosine kinase [Homo sapiens]; Length=675 |
KIN_1M17A_0131 |
2003/08/25 |
29.72% (985-1307) |
1e-121 |
1M17 |
Erlotinib |
*1 |
insulin-like growth factor 1 receptor precursor [Homo sapiens]###gi 2144422 pir IGHUR1 insulin-like growth factor 1 receptor precursor - human###gi 804990 emb CAA28030.1 IGF-I receptor [Homo sapiens]; Length=1367 |
KIN_1M17A_0132 |
2003/08/25 |
29.82% (468-795) |
1e-128 |
1M17 |
Erlotinib |
*1 |
keratinocyte growth factor receptor 2 isoform BEK [Homo sapiens]; Length=819 |
KIN_1M17A_0133 |
2003/08/25 |
29.82% (381-708) |
1e-127 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 11 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=732 |
KIN_1M17A_0134 |
2003/08/25 |
29.82% (372-699) |
1e-127 |
1M17 |
Erlotinib |
*1 |
Similar to fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) [Homo sapiens]; Length=723 |
KIN_1M17A_0135 |
2003/08/25 |
32.40% (223-502) |
1e-113 |
1M17 |
Erlotinib |
*1 |
fyn-related kinase [Homo sapiens]###gi 2117802 pir I38396 protein-tyrosine kinase (EC 2.7.1.112) FRK - human###gi 392888 gb AAA18284.1 SRC-like tyrosine kinase###gi 15277744 gb AAH12916.1 AAH12916 Similar to fyn-related kinase [Homo sapiens]###gi 741031 prf 2006289A src-like Tyr kinase; Length=505 |
KIN_1M17A_0136 |
2003/08/25 |
29.70% (539-838) |
1e-111 |
1M17 |
Erlotinib |
*1 |
neurotrophic tyrosine kinase, receptor, type 2 [Homo sapiens]###gi 18369863 gb AAL67965.1 AF410899_1 neurotrophin receptor tyrosine kinase type 2 [Homo sapiens]; Length=838 |
KIN_1M17A_0137 |
2003/08/25 |
29.02% (927-1180) |
5e-70 |
1M17 |
Erlotinib |
*1 |
membrane protein [Homo sapiens]###gi 186675 gb AAA59459.1 receptor tyrosine kinase; Length=1354 |
KIN_1M17A_0138 |
2003/08/25 |
30.96% (231-503) |
1e-110 |
1M17 |
Erlotinib |
*1 |
PTK homologous protein (AA 1-507) [Homo sapiens]; Length=507 |
KIN_1M17A_0139 |
2003/08/25 |
30.12% (352-673) |
1e-123 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 3 isoform 2 precursor; hydroxyaryl-protein kinase; tyrosine kinase JTK4 [Homo sapiens]###gi 7533125 gb AAF63380.1 AF245114_1 fibroblast growth factor receptor 3 [Homo sapiens]; Length=694 |
KIN_1M17A_0140 |
2003/08/25 |
30.94% (531-848) |
1e-105 |
1M17 |
Erlotinib |
*1 |
AXL receptor tyrosine kinase isoform 1; AXL transforming sequence/gene; oncogene AXL [Homo sapiens]###gi 107964 pir A41527 protein-tyrosine kinase (EC 2.7.1.112) axl precursor, major splice form - human; Length=894 |
KIN_1M17A_0141 |
2003/08/25 |
30.94% (531-848) |
1e-105 |
1M17 |
Erlotinib |
*1 |
unnamed protein product [Homo sapiens]###gi 238775 gb AAB20305.1 putative tyrosine kinase receptor [Homo sapiens]; Length=894 |
KIN_1M17A_0142 |
2003/08/25 |
30.65% (419-741) |
1e-117 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 4 isoform 2 precursor; tyrosine kinase related to fibroblast growth factor receptor; tyrosylprotein kinase; protein-tyrosine kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=762 |
KIN_1M17A_0143 |
2003/08/25 |
30.65% (419-741) |
1e-117 |
1M17 |
Erlotinib |
*1 |
AF202063_1 fibroblast growth factor receptor 4, soluble-form splice variant [Homo sapiens]; Length=762 |
KIN_1M17A_0144 |
2003/08/25 |
22.59% (99-397) |
2e-51 |
1M17 |
Erlotinib |
*1 |
AF251059_1 kinase domain protein [Homo sapiens]; Length=422 |
KIN_1M17A_0145 |
2003/08/25 |
32.97% (190-450) |
2e-94 |
1M17 |
Erlotinib |
*1 |
c-src tyrosine kinase [Homo sapiens]###gi 88519 pir JH0559 protein-tyrosine kinase (EC 2.7.1.112) CSK - human###gi 30256 emb CAA42556.1 c-src-kinase [Homo sapiens]###gi 30315 emb CAA42713.1 put. cytoplasmic tyrosine kinase [Homo sapiens]###gi 6077093 emb CAB58562.1 protein tyrosine kinase [Homo sapiens]; Length=450 |
KIN_1M17A_0146 |
2003/08/25 |
22.48% (99-394) |
4e-52 |
1M17 |
Erlotinib |
*1 |
hypothetical protein DKFZp761P1010 [Homo sapiens]###gi 11360265 pir T48680 hypothetical protein DKFZp761P1010.1 - human###gi 7669979 emb CAB89250.1 hypothetical protein [Homo sapiens]; Length=422 |
KIN_1M17A_0147 |
2003/08/25 |
35.71% (110-416) |
5e-98 |
1M17 |
Erlotinib |
*1 |
Similar to tyrosine kinase, non-receptor, 2 [Homo sapiens]; Length=528 |
KIN_1M17A_0148 |
2003/08/25 |
34.56% (263-526) |
1e-100 |
1M17 |
Erlotinib |
*1 |
TXK tyrosine kinase; PTK4 protein tyrosine kinase; PTK4 protein tyrosine kinase 4 [Homo sapiens]###gi 7434388 pir I84483 protein-tyrosine kinase (EC 2.7.1.112) TXK - human###gi 684986 gb AAA74557.1 tyrosine kinase; Length=527 |
KIN_1M17A_0149 |
2003/08/25 |
29.19% (436-756) |
1e-104 |
1M17 |
Erlotinib |
*1 |
leukocyte tyrosine kinase [Homo sapiens]###gi 34420 emb CAA43113.1 tyrosine kinase [Homo sapiens]; Length=803 |
KIN_1M17A_0150 |
2003/08/25 |
33.44% (1096-1399) |
1e-107 |
1M17 |
Erlotinib |
*1 |
met proto-oncogene precursor [Homo sapiens]###gi 307196 gb AAA59591.1 MET proto-oncogene protein; Length=1408 |
KIN_1M17A_0151 |
2003/08/25 |
33.11% (101-398) |
4e-75 |
1M17 |
Erlotinib |
*1 |
non-receptor tyosine kinase [Homo sapiens]; Length=661 |
KIN_1M17A_0152 |
2003/08/25 |
32.78% (101-398) |
6e-75 |
1M17 |
Erlotinib |
*1 |
Similar to tyrosine kinase, non-receptor, 1 [Homo sapiens]; Length=661 |
KIN_1M17A_0153 |
2003/08/25 |
30.54% (531-825) |
1e-108 |
1M17 |
Erlotinib |
*1 |
neurotrophic tyrosine kinase, receptor, type 3 [Homo sapiens]###gi 1071852 pir A55178 neurotrophin receptor trkC precursor - human###gi 442390 gb AAA75374.1 TrkC; Length=825 |
KIN_1M17A_0154 |
2003/08/25 |
33.95% (555-819) |
1e-106 |
1M17 |
Erlotinib |
*1 |
fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94); fer (fps/fes related) tyrosine kinase [Homo sapiens]###gi 66833 pir TVHUFE protein-tyrosine kinase (EC 2.7.1.112) fer - human###gi 339715 gb AAA61190.1 tyrosine kinase (FER); Length=822 |
KIN_1M17A_0155 |
2003/08/25 |
30.65% (249-571) |
1e-117 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 4 variant [Homo sapiens]; Length=592 |
KIN_1M17A_0156 |
2003/08/25 |
32.99% (892-1177) |
4e-72 |
1M17 |
Erlotinib |
*1 |
AAH14243 Unknown (protein for MGC:20776) [Homo sapiens]; Length=1187 |
KIN_1M17A_0157 |
2003/08/25 |
29.45% (103-408) |
1e-104 |
1M17 |
Erlotinib |
*1 |
ETS related protein-growth factor receptor tyrosine kinase fusion proteins [Homo sapiens]; Length=408 |
KIN_1M17A_0158 |
2003/08/25 |
27.81% (1100-1418) |
1e-108 |
1M17 |
Erlotinib |
*1 |
gi 2454168 gb AAB71619.1 anaplastic lymphoma kinase [Homo sapiens]; Length=1620 |
KIN_1M17A_0159 |
2003/08/25 |
27.81% (1100-1418) |
1e-108 |
1M17 |
Erlotinib |
*1 |
anaplastic lymphoma kinase Ki-1; ALK tyrosine kinase receptor precursor; CD246 antigen [Homo sapiens]; Length=1620 |
KIN_1M17A_0160 |
2003/08/25 |
27.81% (283-601) |
1e-108 |
1M17 |
Erlotinib |
*1 |
AF390893_1 TRK-fused gene/anaplastic large cell lymphoma kinase extra long form [Homo sapiens]; Length=803 |
KIN_1M17A_0161 |
2003/08/25 |
27.81% (236-554) |
1e-107 |
1M17 |
Erlotinib |
*1 |
AF143407_1 TRK-fused gene/anaplastic lymphoma kinase (Ki-1) fusion protein long form [Homo sapiens]; Length=756 |
KIN_1M17A_0162 |
2003/08/25 |
27.81% (181-499) |
1e-107 |
1M17 |
Erlotinib |
*1 |
AF125093_1 TRK-fused gene-anaplastic lymphoma kinase fusion protein [Homo sapiens]; Length=701 |
KIN_1M17A_0163 |
2003/08/25 |
30.00% (471-796) |
1e-121 |
1M17 |
Erlotinib |
*1 |
K-sam-IIO2 [Homo sapiens]; Length=817 |
KIN_1M17A_0164 |
2003/08/25 |
29.78% (204-472) |
1e-109 |
1M17 |
Erlotinib |
*1 |
protein-tyrosine kinase fyn isoform c; proto-oncogene tyrosine-protein kinase fyn; src/yes-related novel gene; src-like kinase; c-syn protooncogene; tyrosine kinase p59fyn(T); OKT3-induced calcium influx regulator [Homo sapiens]###gi 21618480 gb AAH32496.1 Unknown (protein for MGC:45350) [Homo sapiens]; Length=482 |
KIN_1M17A_0165 |
2003/08/25 |
33.77% (1078-1381) |
1e-108 |
1M17 |
Erlotinib |
*1 |
gi 66818 pir TVHUME hepatocyte growth factor receptor precursor - human###gi 6006555 emb CAB56793.1 proto-oncogene [Homo sapiens]; Length=1390 |
KIN_1M17A_0166 |
2003/08/25 |
28.57% (784-1068) |
1e-80 |
1M17 |
Erlotinib |
*1 |
PTK7 protein tyrosine kinase 7 isoform a precursor; colon carcinoma kinase-4; protein-tyrosine kinase PTK7 [Homo sapiens]###gi 15808059 gb AAC50484.2 transmembrane receptor precursor [Homo sapiens]###gi 17432421 gb AAL39062.1 protein tyrosine kinase-7 [Homo sapiens]###gi 22725629 gb AAN04862.1 transmembrane receptor precursor PTK7-1 [Homo sapiens]; Length=1070 |
KIN_1M17A_0167 |
2003/08/25 |
35.71% (110-416) |
7e-98 |
1M17 |
Erlotinib |
*1 |
activated p21cdc42Hs kinase [Homo sapiens]###gi 8850245 gb AAA53570.2 activated p21cdc42Hs kinase [Homo sapiens]; Length=1036 |
KIN_1M17A_0168 |
2003/08/25 |
28.57% (728-1012) |
1e-80 |
1M17 |
Erlotinib |
*1 |
PTK7 protein tyrosine kinase 7 isoform d precursor; colon carcinoma kinase-4; protein-tyrosine kinase PTK7 [Homo sapiens]###gi 22725635 gb AAN04865.1 transmembrane receptor precursor PTK7-4 [Homo sapiens]; Length=1014 |
KIN_1M17A_0169 |
2003/08/25 |
31.31% (836-1131) |
3e-77 |
1M17 |
Erlotinib |
*1 |
JW0091 Janus kinase (EC 2.7.-.-) 2 - human###gi 3068752 gb AAC23982.1 Jak2 kinase [Homo sapiens]; Length=1132 |
KIN_1M17A_0170 |
2003/08/25 |
30.26% (315-615) |
1e-100 |
1M17 |
Erlotinib |
*1 |
trk gene product (aa 1-641) [Homo sapiens]###gi 224906 prf 1203383A gene oncD; Length=641 |
KIN_1M17A_0171 |
2003/08/25 |
31.31% (836-1131) |
8e-77 |
1M17 |
Erlotinib |
*1 |
Jak2 kinase [Homo sapiens]; Length=1132 |
KIN_1M17A_0172 |
2003/08/25 |
32.07% (840-1128) |
3e-77 |
1M17 |
Erlotinib |
*1 |
Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens]; Length=1129 |
KIN_1M17A_0173 |
2003/08/25 |
31.72% (838-1126) |
3e-77 |
1M17 |
Erlotinib |
*1 |
Janus kinase 2; tyrosine-protein kinase JAK2 [Homo sapiens]###gi 2570359 gb AAB82092.1 receptor-associated tyrosine kinase [Homo sapiens]###gi 17384438 emb CAD13329.1 bA39K24.1 (Janus kinase 2 (a protein tyrosine kinase)) [Homo sapiens]; Length=1132 |
KIN_1M17A_0174 |
2003/08/25 |
35.50% (237-536) |
1e-115 |
1M17 |
Erlotinib |
*1 |
v-abl Abelson murine leukemia viral oncogene homolog 2 isoform a; Abelson murine leukemia viral (v-abl) oncogene homolog 2; Abelson-related gene [Homo sapiens]###gi 88520 pir B35962 protein-tyrosine kinase (EC 2.7.1.112) I, splice form A - human; Length=1146 |
KIN_1M17A_0175 |
2003/08/25 |
35.28% (273-574) |
1e-115 |
1M17 |
Erlotinib |
*1 |
v-abl Abelson murine leukemia viral oncogene homolog 2 isoform b; Abelson murine leukemia viral (v-abl) oncogene homolog 2; Abelson-related gene [Homo sapiens]###gi 88521 pir A35962 protein-tyrosine kinase (EC 2.7.1.112) I, splice form B - human###gi 178993 gb AAA35553.1 arg tyrosine kinase; Length=1182 |
KIN_1M17A_0176 |
2003/08/25 |
29.37% (933-1183) |
6e-70 |
1M17 |
Erlotinib |
*1 |
vascular endothelial growth factor receptor 2 [Homo sapiens]; Length=1356 |
KIN_1M17A_0177 |
2003/08/25 |
32.06% (351-629) |
1e-101 |
1M17 |
Erlotinib |
*1 |
tec protein tyrosine kinase [Homo sapiens]###gi 2117818 pir I56997 protein-tyrosine kinase (EC 2.7.1.112) tec - human###gi 474304 dbj BAA06171.1 Tec protein-tyrosine kinase [Homo sapiens]; Length=631 |
KIN_1M17A_0178 |
2003/08/25 |
33.10% (382-657) |
3e-98 |
1M17 |
Erlotinib |
*1 |
Bruton's agammaglobulinemia tyrosine kinase [Homo sapiens]; Length=657 |
KIN_1M17A_0179 |
2003/08/25 |
33.69% (206-476) |
1e-100 |
1M17 |
Erlotinib |
*1 |
chromosome 20 open reading frame 148 [Homo sapiens]; Length=477 |
KIN_1M17A_0180 |
2003/08/25 |
29.52% (356-683) |
1e-126 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 12 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]; Length=707 |
KIN_1M17A_0181 |
2003/08/25 |
27.89% (648-939) |
5e-81 |
1M17 |
Erlotinib |
*1 |
PTK7 protein tyrosine kinase 7 isoform c precursor; colon carcinoma kinase-4; protein-tyrosine kinase PTK7 [Homo sapiens]###gi 22725633 gb AAN04864.1 transmembrane receptor precursor PTK7-3 [Homo sapiens]; Length=940 |
KIN_1M17A_0182 |
2003/08/25 |
31.23% (404-717) |
1e-102 |
1M17 |
Erlotinib |
*1 |
focal adhesion kinase [Homo sapiens]###gi 1588320 prf 2208337A focal adhesion kinase; Length=1009 |
KIN_1M17A_0183 |
2003/08/25 |
33.69% (217-487) |
1e-100 |
1M17 |
Erlotinib |
*1 |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; chromosome 20 open reading frame 148 [Homo sapiens]###gi 11137518 emb CAC15526.1 dJ697K14.1 (novel tyrosine kinase) [Homo sapiens]; Length=488 |
KIN_1M17A_0184 |
2003/08/25 |
33.68% (1-284) |
1e-117 |
1M17 |
Erlotinib |
*1 |
large erk kinase [Homo sapiens]; Length=347 |
KIN_1M17A_0185 |
2003/08/25 |
32.39% (250-524) |
1e-119 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase p59fyn(T) [Homo sapiens]; Length=534 |
KIN_1M17A_0186 |
2003/08/25 |
31.23% (404-717) |
1e-102 |
1M17 |
Erlotinib |
*1 |
PTK2B protein tyrosine kinase 2 beta isoform a; cell adhesion kinase beta; focal adhesion kinase 2; protein kinase B; proline-rich tyrosine kinase 2; CAK beta; related adhesion focal tyrosine kinase; calcium-dependent tyrosine kinase; protein tyrosine kinase 2 beta [Homo sapiens]###gi 27886586 ref NP_775266.1 PTK2B protein tyrosine kinase 2 beta isoform a; cell adhesion kinase beta; focal adhesion kinase 2; protein kinase B; proline-rich tyrosine kinase 2; CAK beta; related adhesion focal tyrosine kinase; calcium-dependent tyrosine kinase; protein tyrosine kinase 2 beta [Homo sapiens]###gi 27886590 ref NP_775268.1 PTK2B protein tyrosine kinase 2 beta isoform a; cell adhesion kinase beta; focal adhesion kinase 2; protein kinase B; proline-rich tyrosine kinase 2; CAK beta; related adhesion focal tyrosine kinase; calcium-dependent tyrosine kinase; protein tyrosine kinase 2 beta [Homo sapiens]###gi 2136336 pir S60248 protein-tyrosine kinase (EC 2.7.1.112) CAK-beta - human###gi 988305 gb AAC50203.1 PYK2###gi 1245924 gb AAB35701.1 related adhesion focal tyrosine kinase; RAFTK [Homo sapiens]###gi 27503699 gb AAH42599.1 protein tyrosine kinase 2 beta [Homo sapiens]###gi 1582983 prf 2119367A protein Tyr kinase PYK2; Length=1009 |
KIN_1M17A_0187 |
2003/08/25 |
27.27% (11-267) |
2e-54 |
1M17 |
Erlotinib |
*1 |
MLTK-alpha [Homo sapiens]; Length=800 |
KIN_1M17A_0188 |
2003/08/25 |
26.37% (11-284) |
4e-54 |
1M17 |
Erlotinib |
*1 |
AF465843_1 cervical cancer suppressor gene-4 protein [Homo sapiens]; Length=312 |
KIN_1M17A_0189 |
2003/08/25 |
34.39% (344-619) |
1e-98 |
1M17 |
Erlotinib |
*1 |
EMT [Homo sapiens]; Length=620 |
KIN_1M17A_0190 |
2003/08/25 |
33.33% (383-658) |
3e-98 |
1M17 |
Erlotinib |
*1 |
Bruton agammaglobulinemia tyrosine kinase [Homo sapiens]###gi 2117814 pir A45184 protein-tyrosine kinase (EC 2.7.1.112), nonreceptor type, BTK - human###gi 312467 emb CAA41728.1 agammaglobulinaemia tyrosine kinase [Homo sapiens]###gi 517438 gb AAB60639.1 Bruton agammaglobulinemia tyrosine kinase###gi 632960 gb AAA61479.1 Bruton agammaglobulinemia###gi 1684918 gb AAB64205.1 Bruton's tyrosine kinase [Homo sapiens]###gi 444280 prf 1906334A protein Tyr kinase; Length=659 |
KIN_1M17A_0191 |
2003/08/25 |
36.27% (227-513) |
1e-116 |
1M17 |
Erlotinib |
*1 |
gi 28237 emb CAA34438.1 p150 protein (AA 1-1130) [Homo sapiens]; Length=1130 |
KIN_1M17A_0192 |
2003/08/25 |
36.15% (246-533) |
1e-116 |
1M17 |
Erlotinib |
*1 |
proto-oncogene tyrosine-protein kinase [Homo sapiens]; Length=1149 |
KIN_1M17A_0193 |
2003/08/25 |
36.15% (227-514) |
1e-116 |
1M17 |
Erlotinib |
*1 |
proto-oncogene tyrosine-protein kinase [Homo sapiens]; Length=1130 |
KIN_1M17A_0194 |
2003/08/25 |
31.23% (404-717) |
1e-102 |
1M17 |
Erlotinib |
*1 |
cell adhesion kinase beta [Homo sapiens]; Length=1009 |
KIN_1M17A_0195 |
2003/08/25 |
32.20% (99-386) |
1e-113 |
1M17 |
Erlotinib |
*1 |
bA702N8.1 (fyn-related kinase) [Homo sapiens]; Length=390 |
KIN_1M17A_0196 |
2003/08/25 |
38.38% (348-628) |
3e-91 |
1M17 |
Erlotinib |
*1 |
protein tyrosin kinase [Homo sapiens]; Length=630 |
KIN_1M17A_0197 |
2003/08/25 |
38.38% (330-610) |
4e-91 |
1M17 |
Erlotinib |
*1 |
protein-tyrosine kinase [Homo sapiens]###gi 15030259 gb AAH11399.1 AAH11399 Similar to spleen tyrosine kinase [Homo sapiens]; Length=612 |
KIN_1M17A_0198 |
2003/08/25 |
33.58% (186-448) |
5e-96 |
1M17 |
Erlotinib |
*1 |
PTK6 protein tyrosine kinase 6; breast tumor kinase; protein-tyrosine kinase BRK [Homo sapiens]###gi 1082891 pir S49016 protein-tyrosine kinase (EC 2.7.1.112) brk - human###gi 515026 emb CAA55295.1 tyrosine kinase [Homo sapiens]###gi 3551753 gb AAC34935.1 non-receptor type protein tyrosine kinase [Homo sapiens]###gi 11137517 emb CAC15525.1 dJ697K14.2 (tyrosine kinase) [Homo sapiens]; Length=451 |
KIN_1M17A_0199 |
2003/08/25 |
28.30% (230-532) |
1e-113 |
1M17 |
Erlotinib |
*1 |
AAH13200 Unknown (protein for MGC:17196) [Homo sapiens]; Length=539 |
KIN_1M17A_0200 |
2003/08/25 |
34.39% (344-619) |
8e-99 |
1M17 |
Erlotinib |
*1 |
IL2-inducible T-cell kinase; homolog of mouse T-cell itk/tsk; tyrosine-protein kinase ITK/TSK; tyrosine-protein kinase LYK [Homo sapiens]###gi 423136 pir S33253 protein-tyrosine kinase (EC 2.7.1.112), T-cell-specific itk/ tsk/emt - human###gi 307508 gb AAA36748.1 tyrosine kinase###gi 399658 dbj BAA02873.1 ITK [Homo sapiens]; Length=620 |
KIN_1M17A_0201 |
2003/08/25 |
29.82% (471-798) |
1e-128 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 2 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 345843 pir A45081 fibroblast growth factor receptor 2 IIIb, FGFR2 IIIb - human###gi 182567 gb AAA52449.1 'human FGFR2 IIIb'###gi 21667446 gb AAM74056.1 AF487553_1 fibroblast growth factor receptor 2 [Homo sapiens]; Length=822 |
KIN_1M17A_0202 |
2003/08/25 |
29.82% (358-685) |
1e-127 |
1M17 |
Erlotinib |
*1 |
isoform of FGFR2 [Homo sapiens]; Length=709 |
KIN_1M17A_0203 |
2003/08/25 |
29.82% (354-681) |
1e-127 |
1M17 |
Erlotinib |
*1 |
fibroblast growth factor receptor 2 isoform 3 precursor; keratinocyte growth factor receptor; K-sam protein; protein tyrosine kinase, receptor like 14; FGF receptor; bacteria-expressed kinase; fibroblast growth factor receptor BEK; tyrosylprotein kinase; hydroxyaryl-protein kinase [Homo sapiens]###gi 186782 gb AAA59471.1 fibroblast growth factor receptor; Length=705 |
KIN_1M17A_0204 |
2003/08/25 |
27.80% (738-1029) |
8e-81 |
1M17 |
Erlotinib |
*1 |
PTK7 protein tyrosine kinase 7 isoform b precursor; colon carcinoma kinase-4; protein-tyrosine kinase PTK7 [Homo sapiens]###gi 22725631 gb AAN04863.1 transmembrane receptor precursor PTK7-2 [Homo sapiens]; Length=1030 |
KIN_1M17A_0205 |
2003/08/25 |
27.64% (11-267) |
2e-54 |
1M17 |
Erlotinib |
*1 |
sterile-alpha motif and leucine zipper containing kinase AZK; mixed lineage kinase with a leucine zipper and a sterile alpha motif; mixed lineage kinase-related kinase [Homo sapiens]###gi 7649266 gb AAF65822.1 AF251441_1 sterile-alpha motif and leucine zipper containing kinase AZK [Homo sapiens]###gi 19172411 gb AAL85891.1 AF480461_1 mixed lineage kinase-related kinase MRK-alpha [Homo sapiens]; Length=800 |
KIN_1M17A_0206 |
2003/08/25 |
29.39% (545-855) |
2e-97 |
1M17 |
Erlotinib |
*1 |
discoidin domain receptor family, member 2 precursor; neurotrophic tyrosine kinase, receptor-related 3; neurotrophic tyrosine kinase receptor related 3 [Homo sapiens]###gi 631349 pir S42621 protein-tyrosine kinase (EC 2.7.1.112) - human###gi 433338 emb CAA52777.1 protein-tyrosine kinase [Homo sapiens]; Length=855 |
KIN_1M17A_0207 |
2003/08/25 |
27.27% (11-267) |
9e-54 |
1M17 |
Erlotinib |
*1 |
mixed lineage kinase-related kinase MRK-beta; mixed lineage kinase with a leucine zipper and a sterile alpha motif; mixed lineage kinase-related kinase [Homo sapiens]###gi 10798814 dbj BAB16445.1 MLTK-beta [Homo sapiens]###gi 12655099 gb AAH01401.1 AAH01401 Similar to sterile-alpha motif and leucine zipper containing kinase AZK [Homo sapiens]###gi 13022039 gb AAK11615.1 mixed lineage kinase [Homo sapiens]###gi 19172413 gb AAL85892.1 AF480462_1 mixed lineage kinase-related kinase MRK-beta [Homo sapiens]; Length=455 |
KIN_1M17A_0208 |
2003/08/25 |
27.17% (11-268) |
2e-54 |
1M17 |
Erlotinib |
*1 |
mixed lineage kinase [Homo sapiens]; Length=800 |
KIN_1M17A_0209 |
2003/08/25 |
37.23% (354-632) |
3e-91 |
1M17 |
Erlotinib |
*1 |
spleen tyrosine kinase [Homo sapiens]###gi 627588 pir A53596 protein-tyrosine kinase (EC 2.7.1.112) syk - human###gi 479013 gb AAA36526.1 protein tyrosine kinase###gi 12804209 gb AAH02962.1 AAH02962 Similar to spleen tyrosine kinase [Homo sapiens]###gi 12804475 gb AAH01645.1 AAH01645 Similar to spleen tyrosine kinase [Homo sapiens]; Length=635 |
KIN_1M17A_0210 |
2003/08/25 |
34.15% (819-1104) |
4e-72 |
1M17 |
Erlotinib |
*1 |
gi 21263106 gb AAM44860.1 AF513860_1 Janus kinase 3 (a protein tyrosine kinase, leukocyte) [Homo sapiens]; Length=1124 |
KIN_1M17A_0211 |
2003/08/25 |
32.13% (809-1112) |
1e-70 |
1M17 |
Erlotinib |
*1 |
Janus kinase 3; L-JAK [Homo sapiens]###gi 1082565 pir A55747 L-JAK protein-tyrosine kinase - human###gi 508731 gb AAA19626.1 JAK family protein tyrosine kinase; Length=1124 |
KIN_1M17A_0212 |
2003/08/25 |
33.00% (815-1113) |
6e-72 |
1M17 |
Erlotinib |
*1 |
JAK3 [Homo sapiens]; Length=1124 |
KIN_1M17A_0213 |
2003/08/25 |
30.38% (179-457) |
3e-94 |
1M17 |
Erlotinib |
*1 |
megakaryocyte-associated tyrosine kinase isoform c; Csk-homologous kinase; tyrosine-protein kinase CTK; protein kinase HYL; hematopoietic consensus tyrosine-lacking kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase; Csk-type protein tyrosine kinase; HYL tyrosine kinase; tyrosine kinase MATK; leukocyte carboxyl-terminal src kinase related gene [Homo sapiens]; Length=466 |
KIN_1M17A_0214 |
2003/08/25 |
30.27% (221-500) |
5e-94 |
1M17 |
Erlotinib |
*1 |
megakaryocyte-associated tyrosine kinase isoform b; Csk-homologous kinase; tyrosine-protein kinase CTK; protein kinase HYL; hematopoietic consensus tyrosine-lacking kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase; Csk-type protein tyrosine kinase; HYL tyrosine kinase; tyrosine kinase MATK; leukocyte carboxyl-terminal src kinase related gene [Homo sapiens]; Length=508 |
KIN_1M17A_0215 |
2003/08/25 |
30.24% (222-498) |
6e-94 |
1M17 |
Erlotinib |
*1 |
megakaryocyte-associated tyrosine kinase isoform a; Csk-homologous kinase; tyrosine-protein kinase CTK; protein kinase HYL; hematopoietic consensus tyrosine-lacking kinase; tyrosylprotein kinase; hydroxyaryl-protein kinase; Csk-type protein tyrosine kinase; HYL tyrosine kinase; tyrosine kinase MATK; leukocyte carboxyl-terminal src kinase related gene [Homo sapiens]###gi 1082751 pir A55625 protein-tyrosine kinase (EC 2.7.1.112) matk, short splice form - human###gi 557272 emb CAA54493.1 HYL tyrosine kinase [Homo sapiens]###gi 896220 gb AAC60645.1 AAC60645 megakaryocyte-associated tyrosine kinase [Homo sapiens]###gi 12652729 gb AAH00114.1 AAH00114 megakaryocyte-associated tyrosine kinase [Homo sapiens]###gi 13111883 gb AAH03109.1 AAH03109 megakaryocyte-associated tyrosine kinase [Homo sapiens]; Length=507 |
KIN_1M17A_0216 |
2003/08/25 |
30.14% (238-515) |
3e-94 |
1M17 |
Erlotinib |
*1 |
hypothetical protein [Homo sapiens]; Length=523 |
KIN_1M17A_0217 |
2003/08/25 |
27.27% (11-267) |
2e-54 |
1M17 |
Erlotinib |
*1 |
plaucible mixed-lineage kinase protein [Homo sapiens]; Length=800 |
KIN_1M17A_0218 |
2003/08/25 |
27.81% (160-478) |
1e-107 |
1M17 |
Erlotinib |
*1 |
p80 protein [Homo sapiens]; Length=680 |
KIN_1M17A_0219 |
2003/08/25 |
31.37% (1940-2260) |
1e-110 |
1M17 |
Erlotinib |
*1 |
proto-oncogene c-ros-1 protein precursor; transmembrane tyrosine-specific protein kinase; v-ros avian UR2 sarcoma virus oncogene homolog 1; proto-oncogene tyrosine-protein kinase ROS [Homo sapiens]; Length=2347 |
KIN_1M17A_0220 |
2003/08/25 |
28.12% (553-871) |
7e-96 |
1M17 |
Erlotinib |
*1 |
A49508 protein-tyrosine kinase (EC 2.7.1.112) trkE precursor - human###gi 400463 emb CAA52915.1 TrkE [Homo sapiens]###gi 732800 emb CAA82335.1 receptor tyrosine kinase [Homo sapiens]###gi 1160925 gb AAB05208.1 receptor kinase###gi 14250530 gb AAH08716.1 AAH08716 discoidin domain receptor family, member 1 [Homo sapiens]###gi 15426563 gb AAH13400.1 AAH13400 Unknown (protein for MGC:3909) [Homo sapiens]; Length=876 |
KIN_1M17A_0221 |
2003/08/25 |
25.58% (3-299) |
4e-55 |
1M17 |
Erlotinib |
*1 |
similar to KIAA0641 protein [Homo sapiens]; Length=1271 |
KIN_1M17A_0222 |
2003/08/25 |
25.25% (57-354) |
4e-55 |
1M17 |
Erlotinib |
*1 |
KIAA0641 protein [Homo sapiens]; Length=1326 |
KIN_1M17A_0223 |
2003/08/25 |
26.43% (14-285) |
4e-51 |
1M17 |
Erlotinib |
*1 |
raf related protein [Homo sapiens]; Length=298 |
KIN_1M17A_0224 |
2003/08/25 |
28.77% (181-457) |
6e-90 |
1M17 |
Erlotinib |
*1 |
leukocyte carboxyl-terminal src kinase related gene [Homo sapiens]; Length=465 |
KIN_1M17A_0225 |
2003/08/25 |
28.04% (552-870) |
7e-96 |
1M17 |
Erlotinib |
*1 |
discoidin receptor tyrosine kinase isoform b; PTK3A protein tyrosine kinase 3A; cell adhesion kinase; epithelial discoidin domain receptor 1; neurotrophic tyrosine kinase, receptor, type 4; neuroepithelial tyrosine kinase; mammarian carcinoma kinase 10 [Homo sapiens]; Length=875 |
KIN_1M17A_0226 |
2003/08/25 |
24.68% (303-606) |
5e-53 |
1M17 |
Erlotinib |
*1 |
v-raf murine sarcoma 3611 viral oncogene homolog 1; Oncogene ARAF1 [Homo sapiens]###gi 625217 pir TVHUAF protein kinase A-raf-1 (EC 2.7.1.-) - human###gi 780127 gb AAA65219.1 ARAF1###gi 1405977 gb AAB03517.1 Ser/Thr protein kinase###gi 12803301 gb AAH02466.1 AAH02466 v-raf murine sarcoma 3611 viral oncogene homolog 1 [Homo sapiens]; Length=606 |
KIN_1M17A_0227 |
2003/08/25 |
24.68% (303-606) |
4e-53 |
1M17 |
Erlotinib |
*1 |
ORF (A-raf) (AA 1-606) [Homo sapiens]; Length=606 |
KIN_1M17A_0228 |
2003/08/25 |
31.25% (103-421) |
6e-73 |
1M17 |
Erlotinib |
*1 |
tyrosine kinase, non-receptor, 1; tyrosine kinase non-receptor 1; tyrosine kinase non-receceptor 1 [Homo sapiens]###gi 1256003 gb AAC50427.1 tyrosine kinase; Length=666 |
KIN_1M17A_0229 |
2003/08/25 |
28.04% (592-910) |
6e-96 |
1M17 |
Erlotinib |
*1 |
gi 306475 gb AAA18019.1 tyrosine protein kinase###gi 15277225 dbj BAB63318.1 Receptor tyrosine kinase [Homo sapiens]###gi 27544401 dbj BAC54935.1 receptor tyrosine kinase [Homo sapiens]; Length=913 |
KIN_1M17A_0230 |
2003/08/25 |
29.25% (99-432) |
1e-120 |
1M17 |
Erlotinib |
*1 |
similar to Eph receptor A6 [Mus musculus] [Homo sapiens]; Length=435 |
KIN_1M17A_0231 |
2003/08/25 |
28.30% (637-942) |
3e-81 |
1M17 |
Erlotinib |
*1 |
ephrin receptor EphB6 precursor; ephrin receptor EphB6 [Homo sapiens]###gi 7446403 pir JC5526 kinase-defective Eph-family receptor protein precursor - human###gi 2281008 dbj BAA21560.1 Eph-family protein [Homo sapiens]; Length=1006 |
KIN_1M17A_0232 |
2003/08/25 |
24.28% (114-423) |
3e-59 |
1M17 |
Erlotinib |
*1 |
similar to KIAA1883 protein [Homo sapiens]; Length=1460 |
KIN_1M17A_0233 |
2003/08/25 |
23.77% (332-641) |
4e-56 |
1M17 |
Erlotinib |
*1 |
AC006344_3 serine/threonine protein kinase; similar to B-raf proto-oncogene; multiple spliced forms; exon 7 is unusually highly conserved at the nucleotide level; similar to Q04982 (PID:g464647) [Homo sapiens]; Length=651 |
KIN_1M17A_0234 |
2003/08/25 |
23.90% (134-448) |
3e-59 |
1M17 |
Erlotinib |
*1 |
KIAA1883 protein [Homo sapiens]; Length=1480 |
KIN_1M17A_0235 |
2003/08/25 |
25.14% (384-719) |
5e-94 |
1M17 |
Erlotinib |
*1 |
similar to leukocyte tyrosine kinase [Homo sapiens] [Rattus norvegicus]; Length=806 |
KIN_1M17A_0236 |
2003/08/25 |
27.47% (590-911) |
3e-93 |
1M17 |
Erlotinib |
*1 |
discoidin receptor tyrosine kinase isoform a; PTK3A protein tyrosine kinase 3A; cell adhesion kinase; epithelial discoidin domain receptor 1; neurotrophic tyrosine kinase, receptor, type 4; neuroepithelial tyrosine kinase; mammarian carcinoma kinase 10 [Homo sapiens]###gi 1480250 emb CAA66871.1 discoidin receptor tyrosine kinase [Homo sapiens]; Length=913 |
KIN_1M17A_0237 |
2003/08/25 |
29.43% (118-403) |
9e-56 |
1M17 |
Erlotinib |
*1 |
similar to mixed lineage kinase MLK1 [Homo sapiens] [Mus musculus]; Length=1077 |
KIN_1M17A_0238 |
2003/08/25 |
26.91% (590-914) |
2e-91 |
1M17 |
Erlotinib |
*1 |
discoidin receptor tyrosine kinase isoform c; PTK3A protein tyrosine kinase 3A; cell adhesion kinase; epithelial discoidin domain receptor 1; neurotrophic tyrosine kinase, receptor, type 4; neuroepithelial tyrosine kinase; mammarian carcinoma kinase 10 [Homo sapiens]; Length=919 |
KIN_1M17A_0239 |
2003/08/25 |
25.36% (342-607) |
2e-53 |
1M17 |
Erlotinib |
*1 |
v-raf-1 murine leukemia viral oncogene homolog 1; Oncogene RAF1; raf proto-oncogene serine/threonine protein kinase [Homo sapiens]###gi 66762 pir TVHUF6 protein kinase raf-1 (EC 2.7.1.-) - human###gi 35842 emb CAA27204.1 raf protein (aa 1-648) [Homo sapiens]###gi 17390263 gb AAH18119.1 AAH18119 v-raf-1 murine leukemia viral oncogene homolog 1 [Homo sapiens]; Length=648 |
KIN_1M17A_0240 |
2003/08/25 |
23.77% (446-755) |
4e-56 |
1M17 |
Erlotinib |
*1 |
v-raf murine sarcoma viral oncogene homolog B1; Murine sarcoma viral (v-raf) oncogene homolog B1 [Homo sapiens]###gi 2144413 pir TVHUBF protein kinase B-raf (EC 2.7.1.-) - human###gi 179533 gb AAA35609.1 B-raf protein; Length=765 |
KIN_1M17A_0241 |
2003/08/25 |
30.87% (73-357) |
5e-56 |
1M17 |
Erlotinib |
*1 |
AF251442_1 mixed lineage kinase MLK1 [Homo sapiens]; Length=1066 |
KIN_1M17A_0242 |
2003/08/25 |
28.23% (157-428) |
7e-55 |
1M17 |
Erlotinib |
*1 |
similar to mitogen-activated protein kinase kinase kinase 13; leucine zipper-bearing kinase [Homo sapiens] [Rattus norvegicus]; Length=548 |
KIN_1M17A_0243 |
2003/08/25 |
27.69% (92-380) |
2e-52 |
1M17 |
Erlotinib |
*1 |
similar to mitogen-activated protein kinase kinase kinase 10; mixed lineage kinase 2; MKN28 kinase; MKN28 derived nonreceptor_type serine/threonine kinase [Homo sapiens] [Rattus norvegicus]; Length=1018 |
KIN_1M17A_0244 |
2003/08/25 |
27.33% (106-405) |
1e-51 |
1M17 |
Erlotinib |
*1 |
KIAA1804 protein [Homo sapiens]###gi 17736731 emb CAC84640.1 mixed lineage kinase 4beta [Homo sapiens]; Length=1036 |
KIN_1M17A_0245 |
2003/08/25 |
26.96% (20-321) |
3e-51 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 7 isoform C; transforming growth factor-beta-activated kinase 1; TGF-beta activated kinase 1 [Homo sapiens]###gi 8978252 dbj BAA25027.2 TGF-beta activated kinase 1c [Homo sapiens]; Length=518 |
KIN_1M17A_0246 |
2003/08/25 |
27.56% (105-405) |
8e-51 |
1M17 |
Erlotinib |
*1 |
mixed lineage kinase 4alpha [Homo sapiens]; Length=570 |
KIN_1M17A_0247 |
2003/08/25 |
26.35% (114-385) |
6e-54 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 12; leucine zipper protein kinase; zipper protein kinase; protein kinase MUK; dual leucine zipper kinase DLK [Homo sapiens]; Length=859 |
KIN_1M17A_0248 |
2003/08/25 |
26.35% (114-385) |
6e-54 |
1M17 |
Erlotinib |
*1 |
zipper protein kinase [Homo sapiens]; Length=859 |
KIN_1M17A_0249 |
2003/08/25 |
28.23% (157-428) |
3e-55 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 13; leucine zipper-bearing kinase [Homo sapiens]###gi 2879898 dbj BAA24817.1 leucine zipper bearing kinase [Homo sapiens]; Length=966 |
KIN_1M17A_0250 |
2003/08/25 |
26.96% (20-321) |
8e-51 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 7 isoform A; transforming growth factor-beta-activated kinase 1; TGF-beta activated kinase 1 [Homo sapiens]###gi 7513395 pir JC5955 transforming growth factor-beta activated kinase (EC 2.7.-.-) 1a - human###gi 2924624 dbj BAA25025.1 TGF-beta activated kinase 1a [Homo sapiens]###gi 17389343 gb AAH17715.1 AAH17715 mitogen-activated protein kinase kinase kinase 7 [Homo sapiens]; Length=579 |
KIN_1M17A_0251 |
2003/08/25 |
27.71% (105-407) |
5e-52 |
1M17 |
Erlotinib |
*1 |
dJ862P8.3 (Similar to MAP3K10 (mitogen-activated protein kinase kinase kinase 10)) [Homo sapiens]; Length=564 |
KIN_1M17A_0252 |
2003/08/25 |
28.01% (92-380) |
4e-52 |
1M17 |
Erlotinib |
*1 |
serine/threonine kinase with SH3 domain, leucine zipper domain and proline rich domain [Homo sapiens]; Length=953 |
KIN_1M17A_0253 |
2003/08/25 |
26.96% (20-321) |
6e-51 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 7 isoform B; transforming growth factor-beta-activated kinase 1; TGF-beta activated kinase 1 [Homo sapiens]###gi 7513396 pir JC5956 transforming growth factor-beta activated kinase (EC 2.7.-.-) 1b - human###gi 2924626 dbj BAA25026.1 TGF-beta activated kinase 1b [Homo sapiens]; Length=606 |
KIN_1M17A_0254 |
2003/08/25 |
27.70% (101-383) |
2e-54 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 11; mixed lineage kinase 3; SH3 domain-containing proline-rich kinase; protein-tyrosine kinase PTK1 [Homo sapiens]###gi 1082743 pir A53800 mixed-lineage protein kinase (EC 2.7.1.-) 3 - human###gi 464028 gb AAA19647.1 serine/threonine protein kinase###gi 488296 gb AAA59859.1 protein kinase###gi 15030037 gb AAH11263.1 AAH11263 Similar to mitogen-activated protein kinase kinase kinase 11 [Homo sapiens]###gi 1090771 prf 2019437A protein Tyr kinase I; Length=847 |
KIN_1M17A_0255 |
2003/08/25 |
27.81% (79-367) |
5e-52 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 10; mixed lineage kinase 2; MKN28 kinase; MKN28 derived nonreceptor_type serine/threonine kinase [Homo sapiens]; Length=954 |
KIN_1M17A_0256 |
2003/08/25 |
28.01% (92-380) |
4e-52 |
1M17 |
Erlotinib |
*1 |
gi 2135747 pir S68178 mixed-lineage protein kinase 2 (EC 2.7.1.-) - human###gi 971420 emb CAA62351.1 mixed lineage kinase 2 [Homo sapiens]; Length=954 |
KIN_1M17A_0257 |
2003/08/25 |
30.25% (576-854) |
1e-109 |
1M17 |
Erlotinib |
*1 |
Eph-like receptor tyrosine kinase hEphB1c [Homo sapiens]; Length=943 |
KIN_1M17A_0258 |
2003/08/25 |
26.96% (20-321) |
5e-51 |
1M17 |
Erlotinib |
*1 |
mitogen-activated protein kinase kinase kinase 7 isoform D; transforming growth factor-beta-activated kinase 1; TGF-beta activated kinase 1 [Homo sapiens]###gi 6746615 gb AAF27652.1 AF218074_1 TGF beta-activated kinase splice variant d [Homo sapiens]; Length=491 |